Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanny Al-Samkari

Showing results (71-80 of 201) with videos related to

Pageof 21
Sort By:
Transfusion Medicine Reviews|October 23, 2022
Changing Paradigms in ITP Management: Newer Tools for an Old DiseaseDebbie Jiang, Hanny Al-Samkari, Sandhya R Panch
Haematologica|March 1, 2021
Recognition of thrombotic risk of thrombocytosis in iron deficiencyHanny Al-Samkari, Craig M Kessler, Michael Auerbach
Haematologica|October 2, 2018
Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerationsHanny Al-Samkari, Athena Kritharis, David J Kuter
Blood Reviews|January 1, 2026
Avatrombopag in immune thrombocytopenia and beyond: Current evidence and emerging perspectivesMaría Luisa Lozano, Michele P Lambert, Hanny Al-Samkari
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Cyclin-dependent kinase 4/6 inhibitor-associated thromboembolism: a critical evaluation of the current evidenceNathan W Watson, Joseph J Shatzel, Hanny Al-Samkari
Blood Advances|November 16, 2019
Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significanceMarie A Hollenhorst, Hanny Al-Samkari, David J Kuter
Journal of Thrombosis and Thrombolysis|March 23, 2018
Ofatumumab for acute treatment and prophylaxis of a patient with multiple relapses of acquired thrombotic thrombocytopenic purpuraHanny Al-Samkari, Rachael F Grace, Jean M Connors
American Journal of Hematology|July 4, 2020
Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemiaAndrew B Song, David J Kuter, Hanny Al-Samkari
The New England Journal of Medicine|December 12, 2024
Pomalidomide in Hereditary Hemorrhagic Telangiectasia. ReplyHanny Al-Samkari, Sonya M Thomas, Keith R McCrae
The Lancet. Haematology|May 2, 2022
The case for classical haematology: the impact of a name and the future of a fieldHanny Al-Samkari, Alison W Loren, Alfred I Lee
Pageof 21

Showing results (71-80 of 201) with videos related to

Sort By:
Pageof 21
Transfusion Medicine Reviews|October 23, 2022
Changing Paradigms in ITP Management: Newer Tools for an Old DiseaseDebbie Jiang, Hanny Al-Samkari, Sandhya R Panch
Haematologica|March 1, 2021
Recognition of thrombotic risk of thrombocytosis in iron deficiencyHanny Al-Samkari, Craig M Kessler, Michael Auerbach
Haematologica|October 2, 2018
Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerationsHanny Al-Samkari, Athena Kritharis, David J Kuter
Blood Reviews|January 1, 2026
Avatrombopag in immune thrombocytopenia and beyond: Current evidence and emerging perspectivesMaría Luisa Lozano, Michele P Lambert, Hanny Al-Samkari
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Cyclin-dependent kinase 4/6 inhibitor-associated thromboembolism: a critical evaluation of the current evidenceNathan W Watson, Joseph J Shatzel, Hanny Al-Samkari
Blood Advances|November 16, 2019
Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significanceMarie A Hollenhorst, Hanny Al-Samkari, David J Kuter
Journal of Thrombosis and Thrombolysis|March 23, 2018
Ofatumumab for acute treatment and prophylaxis of a patient with multiple relapses of acquired thrombotic thrombocytopenic purpuraHanny Al-Samkari, Rachael F Grace, Jean M Connors
American Journal of Hematology|July 4, 2020
Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemiaAndrew B Song, David J Kuter, Hanny Al-Samkari
The New England Journal of Medicine|December 12, 2024
Pomalidomide in Hereditary Hemorrhagic Telangiectasia. ReplyHanny Al-Samkari, Sonya M Thomas, Keith R McCrae
The Lancet. Haematology|May 2, 2022
The case for classical haematology: the impact of a name and the future of a fieldHanny Al-Samkari, Alison W Loren, Alfred I Lee
Pageof 21